Diffuse Large B-Cell Lymphoma Clinical Trials

A listing of 33 Diffuse Large B-Cell Lymphoma clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Diffuse Large B-Cell Lymphoma

1 - 12 of 33

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 33 active clinical trials seeking participants for Diffuse Large B-Cell Lymphoma research studies. The states with the highest number of trials for Diffuse Large B-Cell Lymphoma participants are California, Ohio, New York and Texas.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Chronic Cough Research Study

Recruiting

Are you tired of living with chronic cough? Our research study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough.
You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you!

Conditions:

Chronic Cough

Refractory or Unexplained Chronic Cough

Cough

Asthma

Sinusitis

Learn More

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Featured Trial

Stroke Clinical Study

Recruiting

A clinical study for people that suffer with Stroke

Conditions:

Stroke

Learn More

Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

NCT06031194

Recruiting

This study evaluates pharmacogenomic effects on high-dose methotrexate clearance in patients with diffuse large B-cell lymphoma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/25/2025

Locations: Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Conditions: Central Nervous System Lymphoma, Diffuse Large B-Cell Lymphoma

Learn More ›

Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma

NCT04850495

Recruiting

This phase Ib trial seeks to find out the best dose and possible side effects and/or benefits of zanubrutinib in combination with the R-PolaCHP in treating patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). Zanubrutinib is designed to block a protein called Bruton Tyrosine Kinase in order to stop cancer growth. R-CHOP is the acronym for the combination of five drugs: rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. It is the most widely used chemoimmunother... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/11/2025

Locations: Cleveland Clinic, Cleveland, Ohio +2 locations

Conditions: Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma, Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma

Learn More ›

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

NCT04512716

Recruiting

This is a pilot study; patients will receive 131-I apamistamab prior to CAR T-cell infusion in order to determine the maximum tolerated dose of 131-I apamistamab is exceeded at 75 mCi, and if so, to assess the safety of a step-down dose of 50 mCi.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/19/2025

Locations: Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey +6 locations

Conditions: B-ALL, DLBCL, B ALL, Dlbcl-Ci, DLBCL Unclassifiable, DLBCL, Nos Genetic Subtypes, DLBCL Activated B-Cell Type, DLBCL Germinal Center B-Cell Type, Diffuse Large B-cell Lymphoma, HGBL, HGBL, Nos

Learn More ›

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686

Recruiting

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol, are actively receiving treatment with ibrutinib, and who continue to benefit from ibrutinib treatment.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/15/2025

Locations: City of Hope Cancer Center, Duarte, California +173 locations

City of Hope Cancer Center, Duarte, California

University of California San Diego Medical Center, La Jolla, California

University of California Los Angeles, Los Angeles, California

St. Joseph Hospital Center for Cancer Prevention and Treatment, Orange, California

Stanford University Medical Center, Stanford, California

Stanford University, Stanford, California

Norwalk Medical Group, Norwalk, Connecticut

Northwest Georgia Oncology Centers PC, Marietta, Georgia

Northwestern University Hospital, Chicago, Illinois

Indiana University, Goshen, Indiana

Kansas University Medical Center, Westwood, Kansas

Louisville Oncology Suburban - Norton Cancer Institute, Louisville, Kentucky

Dana Farber Cancer Center, Boston, Massachusetts

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Battle Creek Health Systm, Battle Creek, Michigan

Karmanos Cancer Institute - Wayne State University, Detroit, Michigan

Washington University, Saint Louis, Missouri

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Hackensack University Medical Center, Hackensack, New Jersey

Weill Medical College of Cornell University, New York, New York

Memorial Sloan-Kettering Cancer Center, New York, New York

Southeastern Medical Oncology Center, Goldsboro, North Carolina

The Ohio State University- James Cancer Hospital, Columbus, Ohio

Willamette Valley Cancer Center, Eugene, Oregon

Kaiser Permanente, Portland, Oregon

University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Avera Medical Group, Sioux Falls, South Dakota

MD Anderson Cancer Center - University of Texas, Houston, Texas

University of Virginia, Charlottesville, Virginia

University of Washington, Seattle, Washington

West Virginia University, Morgantown, West Virginia

University of Wisconsin Carbone Cancer Center - Wisconsin Institute for Medical Research, Madison, Wisconsin

CEMIC Saavedra, Ciudad Autonoma Buenos Aires, Not set

Fundaleu, Ciudad de Buenos Aires, Not set

Royal Adelaide Hospital, Adelaide, Not set

John Fawkner Cancer Trial Centre, Coburg, Not set

Concord Hospital, Concord, Not set

Austin Health, Heidelberg, Not set

Peter MacCallum Cancer Institute, Melbourne, Not set

Royal Perth Hospital, Perth, Not set

Alfred Hospital, Prahran, Not set

Adventist Health Care Limited trading as San Clinical Trials Unit, Wahroonga, Not set

UZA, Antwerp, Not set

A.Z. Sint Jan, Brugge, Not set

UCL - Saint Luc, Brussels, Not set

UZ Gent - departement oncologie, Gent, Not set

UZ Leuven Gasthuisberg, Leuven, Not set

UCL Mont-Godinne, Yvoir, Not set

Ministerio da Saude Instituto Nacional do Cancer, Rio De Janeiro, Not set

Santa Casa da Misericórdia da Bahia - Hospital Santa Isabel, Salvador, Not set

Instituto de Ensino e Pesquisa São Lucas, Sao Paulo, Not set

Jewish General Hospital, Montreal, Quebec

Peking University People s Hospital, Beijing, Not set

Peking University Third Hospital, Beijing, Not set

Peking University First Hospital, Beijing, Not set

West China Hospital Sichuan University, Chengdu, Not set

Fujian Medical University, Fuzhou, Not set

Sun Yat-sen University Cancer Hospital, Guangzhou, Not set

Zhejiang University First Hospital, Hangzhou, Not set

Ruijin Hospital, Shanghai, Not set

Tangdu hospital the Fourth Military Medical, Shanxi, Not set

The First Affliated Hospital of Soochow University, Suzhou, Not set

The Institute of Hematological disease, Tianjin, Not set

Wuhan Union Hospital, Wuhan, Not set

Fundacion Santa Fe, Bogota, Not set

Fundacion Oftalmologica de Santander - FOSCAL, Floridablanca, Not set

Fakultni nemocnice Brno, Interni hematologicka a onkologicka klinika, Brno, Not set

Fakultni nemocnice Kralovske Vinohrady - Interni hematologicka klinika, Praha 10, Not set

Vseobecna fakultni nemocnice v Praze - I. interni klinika - klinika hematologie, Praha 2, Not set

Hopital Henri Mondor, Creteil, Not set

Hôpital E. Muller, Mulhouse, Not set

Hopital Necker Enfants Malades, Paris cedex 15, Not set

HOPITAL SAINT LOUIS - Hematology / Oncology, Paris, Not set

Hopital Haut Leveque Service Maladie Du Sang, Pessac, Not set

CH LYON SUD - Hematology, Pierre Benite, Not set

CHU de Tours, Tours, Not set

Vivantes Klinikum Spandau-Klinik f. Innere Medizin Hämatologie/Onkologie/Gastroenterologie - Germany, Berlin, Not set

Universitätsklinikum Carl Gustav Carus; Med. Klinik und Poliklinik I - Hämatologische Ambulanz, Haus, Dresden, Not set

Universitätsklinikum Essen; Klinik f. Hämatologie- Germany, Essen, Not set

Justus-Liebig-Universitaet - Medizinische Klinik IV, Haematologie, Gießen, Not set

Universitätsklinikum Heidelberg Med. Klinik IV, Heidelberg, Not set

Universitätsklinikum des Saarlandes, Homburg/Saar, Not set

Gemeinschaftspraxis Dres. Uhle/Müller/Kröning/Jentsch-Ullrich - Germany, Magdeburg, Not set

OnkoNet Marburg GmbH, Marburg, Not set

Universitätsklinikum für Innere Med. III_Hämatologie, Onkologie...- Germany, Ulm, Not set

Laiko General Hospital - 1st department of Internal Medicine, Athens, Not set

G Papanikolaou Hospital of Thessaloniki, Thessalonikis, Not set

Semmelweis Egyetem, I. Belgyogyaszati Klinika, Budapest N/a, Not set

Szegedi Tudomanyegyetem II. Belgyogyaszati Klinika, Szeged, Not set

St James's Hospital, Dublin, Not set

Haemek Medical Center, Afula, Not set

Hillel Yaffe Medical Center - Oncology, Hadera, Not set

Rambam Health Care Campus, Haifa, Not set

Rabin Medical Center Beilinson Campus, Petah Tikva, Not set

Sheba Medical Center, Ramat-Gan, Not set

Tel Aviv Sourasky Medical Center, Tel Aviv, Not set

ASST Grande Ospedale Metropolitano Niguarda, Milano, Not set

DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIA - UNIVERSITà ''LA SAPIENZA'', Roma, Not set

A.O.Citta della Salute e della Scienza di Torino, Torino, Not set

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo ku, Not set

Hiroshima University Hospital, Hiroshima shi, Not set

Hokkaido University Hospital, Sapporo-shi, Not set

National Cancer Center, Goyang-Si, Not set

The Catholic University of Korea Seoul St Mary s Hospital, Seoul, Not set

Oaxaca Site Management Organization S.C., Oaxaca, Not set

VU medisch centrum - Afd.Interne - INT, Amsterdam, Not set

Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza, Brzozow, Not set

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich, Chorzow, Not set

Uniwersyteckie Centrum Kliniczne, Gdansk, Not set

Pratia MCM Krakow, Krakow, Not set

Oddzial Hematologii, Opole, Not set

Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka, Slupsk, Not set

Katedra I Klinika Hematologii Nowotworow Krwi I Transplantacji Szpiku, Wroclaw, Not set

Instituto Portugues de Oncologia, Lisboa, Not set

Hospital De Santa Maria, Lisbon, Not set

Instituto Portugues de Oncologia, Porto, Not set

Auxilio Mutuo Cancer Center, San Juan, Not set

Arkhangelsk Regional Clinical Hospital, Arkhangelsk, Not set

Chelyabinsk Regiona Onc. Center, Chelyabinsk, Not set

Emergency Hospital of Dzerzhinsk, Dzerzhinsk, Not set

Cancer Research Center, Moscow N/a, Not set

S.P. Botkin Moscow City Clinical Hospital, Moscow, Not set

Regional Clinical Hospital n.a.Semashko, Nizhni Novgorod, Not set

Medical Scientific Radiology - Center, Obninsk, Not set

Perm Medical Sanitary Unit#1, Perm, Not set

Republican Hospital named by V.A.Baranova, Petrozavodsk, Not set

Rostov Research Institute of Oncology, Rostov-Na-Donu, Not set

Ryazan Regional Clinical Hospital, Ryazan, Not set

Leningrad region clinical hospital, Saint, Not set

Samara Region Clinical Hospital, Samara, Not set

Federal Center of Heart, Blood and Endocrinology, Sankt-Peterburg, Not set

Oncological dispensary #2, Sochi, Not set

City Clinical Oncology Dispensary, St. Petersburg, Not set

Clinical Research Institute of Hematology and Transfusiology, St.-Petersburg, Not set

Oncology Dispensary of Komi Republic, Syktyvkar, Not set

Hospital Vall d'Hebron, Barcelona N/a, Not set

Inst. Cat. Doncologia-H Duran I Reynals, L'hospitalet De Llobregat, Not set

Hosp. Univ. de La Princesa, Madrid, Not set

Hosp. Gral. Univ. Gregorio Maranon, Madrid, Not set

Hosp. Univ. Infanta Leonor, Madrid, Not set

Fundacion Jimenez Diaz, Madrid, Not set

Clinica Universitaria de Navarra, Pamplona N/a, Not set

Hospital Clinico Universitario Salamanca, Salamanca, Not set

Sahlgrenska University hospital, Hematology Dept, Göteborg, Not set

Skanes universitetssjukhus, Lund, Not set

Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm, Stockholm, Not set

Changhua Cristian Hospital, Changhua County, Not set

Ankara University, Ankara, Not set

American Hospital, Istanbul, Not set

Istanbul University, Istanbul, Not set

Dokuz Eylul Universitesi Tip Fakultesi, Izmir, Not set

Erciyes University, Kayseri, Not set

Communal Nonprofit Enterprise 'Cherkasy Regional Oncology Dispensary Of Cherkasy Regional Council', Cherkasy, Not set

Dnepropetrovsk City Clinical Hospital #4, Regional Hematology Center, Dnepropetrovsk, Not set

SI Grigoriev Institute for Medical Radiology National Academy of Medical Science of Ukraine, Kharkiv, Not set

Khmelnitskiy Regional Hospital, Hematology Department, Khmelnitskiy, Not set

State Institution Scientific Center for Radiation Medicine Academy of Medical Sciences of Ukraine, Kiev, Not set

Institute of Blood Pathology and Transfusion Medicine of AMS of Ukraine, Lviv, Not set

Vinnytsya Regional Clinical Hospital named after M.I.Pirogov, Vinnitsa, Not set

University Hospitals Birmingham NHS Trust,, Birmingham, Not set

Royal Bournemouth Hospital, Bournemouth, Not set

Colchester Hospital University NHS, Colchester, Not set

Beatson West Of Scotland Cancer Centre, Glasgow, Not set

St James's Institute of Oncology, Leeds, Not set

Leicester Royal Infirmary - Haematology, Leicester, Not set

St Bartholomew's Hospital - Dept of Haematology, London, Not set

University College London Hospitals NHSFT, London, Not set

Kings College Hospital, London, Not set

Christie Hospital, Manchester, Not set

Nottingham University Hospitals NHS Trust, Nottingham, Not set

Derriford Hospital, Plymouth, Not set

Royal Hallamshire Hospital, Sheffield, Not set

Southampton General Hospital, Southampton, Not set

Royal Marsden Hospital (Sutton), Sutton, Not set

Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B-cell Lymphoma, Waldenstrom Macroglobulinemia, Chronic Graft Versus Host Disease

Learn More ›

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

NCT05618028

Recruiting

B-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of this study is to assess safety, tolerability, pharmacokinetics and preliminary efficacy of ABBV-525 as a monotherapy. ABBV-525 is an investigational drug being developed for the treatment of B-Cell Malignancies. Study doctors put the participants in groups called treatment arms. Participants will receive ABBV-525 at different doses. Approximately 150 adult... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/15/2025

Locations: University of California Los Angeles /ID# 246357, Los Angeles, California +33 locations

University of California Los Angeles /ID# 246357, Los Angeles, California

Yale University School of Medicine /ID# 259081, New Haven, Connecticut

Mount Sinai Medical Center-Miami Beach /ID# 248251, Miami Beach, Florida

Fort Wayne Medical Oncology and Hematology, Inc /ID# 250113, Fort Wayne, Indiana

Indiana University Melvin and Bren Simon Comprehensive Cancer Center /ID# 259872, Indianapolis, Indiana

Tulane Cancer Center Clinic /ID# 249586, New Orleans, Louisiana

START Midwest /ID# 252359, Grand Rapids, Michigan

Memorial Sloan Kettering Cancer Center-Koch Center /ID# 245459, New York, New York

Levine Cancer Institute /ID# 246363, Charlotte, North Carolina

University Of Cincinnati Medical Center /ID# 262288, Cincinnati, Ohio

University of Texas MD Anderson Cancer Center /ID# 245463, Houston, Texas

University of Utah Health Hospital /ID# 259924, Salt Lake City, Utah

Northwest Medical Specialties - Tacoma /ID# 260376, Tacoma, Washington

Liverpool Hospital /ID# 260191, Liverpool, New South Wales

Monash Health - Monash Medical Centre /ID# 246366, Clayton, Victoria

The Alfred Hospital /ID# 248592, Melbourne, Victoria

UZ Gent /ID# 246462, Gent, Oost-Vlaanderen

Universitair Ziekenhuis Leuven /ID# 246461, Leuven, Vlaams-Brabant

CHRU Lille - Hopital Claude Huriez /ID# 252054, Lille, Nord

IUCT Oncopole /ID# 259409, Toulouse Cedex 9, Occitanie

Charite Universitaetsmedizin Berlin Campus Virchow-Klinikum /ID# 252062, Berlin, Not set

Shamir Medical Center /ID# 257711, Beer Ya'akov, HaMerkaz

The Chaim Sheba Medical Center /ID# 251442, Ramat Gan, Tel-Aviv

Hadassah Medical Center-Hebrew University /ID# 251441, Jerusalem, Yerushalayim

Rabin Medical Center /ID# 257665, Petah Tikva, Not set

Asan Medical Center /ID# 266341, Seoul, Seoul Teugbyeolsi

Institut Català d'Oncologia (ICO) - L'Hospitalet /ID# 246537, L'Hospitalet de Llobregat, Barcelona

Hospital Universitario Vall d'Hebron /ID# 245475, Barcelona, Not set

Hospital Clinic de Barcelona /ID# 246543, Barcelona, Not set

Hospital Universitario Ramon y Cajal /ID# 246540, Madrid, Not set

Hospital Universitario 12 de Octubre /ID# 246538, Madrid, Not set

Leeds Teaching Hospitals NHS Trust /ID# 245470, Leeds, West Yorkshire

The Royal Marsden NHS Foundation Trust /ID# 250324, London, Not set

The Christie Hospital /ID# 250325, Manchester, Not set

Conditions: Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies, Non-Hodgkin's Lymphoma

Learn More ›

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

NCT06717347

Recruiting

The purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading than people who receive standard treatment alone.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/14/2025

Locations: The University of Arizona Cancer Center - North Campus ( Site 0124), Tucson, Arizona +198 locations

The University of Arizona Cancer Center - North Campus ( Site 0124), Tucson, Arizona

Cancer Blood and Specialty Clinic ( Site 0109), Los Alamitos, California

Cedars-Sinai Medical Center ( Site 0115), Los Angeles, California

Bioresearch Partner ( Site 0157), Hialeah, Florida

Cancer Care Specialists of Illinois ( Site 0152), O'Fallon, Illinois

Fort Wayne Medical Oncology and Hematology ( Site 0149), Fort Wayne, Indiana

Cotton O'Neil Cancer Center ( Site 0108), Topeka, Kansas

Corewell Health ( Site 0130), Grand Rapids, Michigan

Truman Medical Center ( Site 0122), Kansas City, Missouri

OptumCare Cancer Care ( Site 0121), Las Vegas, Nevada

Comprehensive Cancer Centers of Nevada ( Site 0113), Las Vegas, Nevada

New York Oncology Hematology, P.C. ( Site 0129), Albany, New York

The University of Tennessee Medical Center ( Site 0142), Knoxville, Tennessee

University of Virginia Cancer Center ( Site 0138), Charlottesville, Virginia

Virginia Cancer Institute ( Site 0148), Richmond, Virginia

Blue Ridge Cancer Care ( Site 0132), Roanoke, Virginia

SSM Health Dean Medical Group ( Site 0140), Madison, Wisconsin

Clinica Adventista Belgrano ( Site 0309), Caba., Buenos Aires

Instituto de Investigaciones Clinicas Mar del Plata ( Site 0306), Mar del Plata, Buenos Aires

Hospital Universitario Austral ( Site 0307), Pilar, Buenos Aires

Hospital Aleman ( Site 0301), Buenos Aites, Caba

Fundacion Estudios Clinicos ( Site 0311), Rosario., Santa Fe

C.I.C.E. 9 de Julio ( Site 0305), San Miguel de Tucuman, Tucuman

Hospital Italiano de Buenos Aires ( Site 0304), Caba, Not set

Clinica EL Castaño ( Site 0312), San Juan, Not set

Townsville University Hospital ( Site 3006), Douglas, Queensland

Grampians Health ( Site 3003), Ballarat, Victoria

Royal Perth Hospital-Haematology ( Site 3004), Perth, Western Australia

AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 1102), Mechelen, Antwerpen

ASBL CHU Helora - Hôpital de Mons - Site Kennedy ( Site 1103), Mons, Hainaut

CEONC ( Site 0412), Cascavel, Parana

Hospital Erasto Gaertner ( Site 0401), Curitiba, Parana

Liga Norte Riograndense Contra o Cancer ( Site 0407), Natal, Rio Grande Do Norte

CEPEN - Centro de Pesquisa e Ensino em Oncologia de Santa Catarina ( Site 0403), Florianópolis, Santa Catarina

Hope ( Site 0413), Ribeirao Preto, Sao Paulo

Clinica Advanze ( Site 0411), Sao Carlos, Sao Paulo

F. F. R. M. São Jose do Rio Preto ( Site 0404), Sjrp, Sao Paulo

Hospital Paulistano ( Site 0406), Sao Paulo, Not set

Lakeridge Health - The R.S. McLaughlin Durham Regional Cancer Centre (MDRCC) ( Site 0206), Oshawa, Ontario

Biocenter ( Site 0510), Concepcion., Biobio

IC La Serena Research ( Site 0504), La Serena, Coquimbo

Oncocentro Valdivia ( Site 0506), Valdivia, Los Rios

Centro de Estudios Clínicos SAGA ( Site 0508), Santiago., Region M. De Santiago

Bradfordhill ( Site 0502), Santiago., Region M. De Santiago

FALP ( Site 0501), Santiago, Region M. De Santiago

Clinica Inmunocel ( Site 0503), Santiago, Region M. De Santiago

Clínica RedSalud Vitacura ( Site 0512), Santiago, Region M. De Santiago

Centro de Investigaciones ( Site 0511), Vina del mar, Valparaiso

Anhui Provincial Cancer Hospital ( Site 3124), Hefei, Anhui

Peking University Third Hospital ( Site 3102), Beijing, Beijing

Beijing Cancer Hospital ( Site 3101), Beijing, Beijing

Chongqing Cancer Hospital ( Site 3113), Chongqing, Chongqing

Fujian Provincial Cancer Hospital. ( Site 3119), Fuzhou, Fujian

The First Affiliated Hospital of Xiamen University ( Site 3120), Xiamen, Fujian

Sun Yat-sen University Cancer Center ( Site 3121), Guangzhou, Guangdong

Zhujiang Hospital of Southern Medical University ( Site 3122), Guangzhou, Guangdong

Affiliated Cancer Hospital of Guangxi Medical University ( Site 3123), Nanning, Guangxi

The Affiliated Hospital of Guizhou Medical University ( Site 3112), Guiyang, Guizhou

Hubei Cancer Hospital ( Site 3125), Wuhan, Hubei

Affiliated Hospital of Nantong University ( Site 3117), Nantong, Jiangsu

Jiangxi Cancer Hospital ( Site 3118), Nanchang, Jiangxi

The First Hospital Of Jilin University ( Site 3103), Changchun, Jilin

Shandong Cancer Hospital ( Site 3108), Jinan, Shandong

LinYi Cancer Hospital ( Site 3104), Linyi, Shandong

Fudan University Shanghai Cancer Center ( Site 3115), Shanghai, Shanghai

Shanxi Cancer Hospital ( Site 3106), Taiyuan, Shanxi

1st Affil Hosp of Med College of Xi'an Jiaotong University ( Site 3107), XI An, Shanxi

Sichuan Cancer Hospital. ( Site 3111), Chengdu, Sichuan

West China Hospital, Sichuan University ( Site 3110), Chengdu, Sichuan

Institute of Hematology and Blood Diseases Hosp CAMS&PUMC ( Site 3105), Tianjin, Tianjin

Yunnan Province Cancer Hospital ( Site 3109), Kunming, Yunnan

The First Affiliated Hospital, Zhejiang Medical University ( Site 3116), Hangzhou, Zhejiang

Hospital Pablo Tobon Uribe ( Site 0604), Medellin, Antioquia

IMAT S.A.S ( Site 0603), Montería, Cordoba

Hospital Universitario San Ignacio ( Site 0607), Bogota., Distrito Capital De Bogota

Oncologos del Occidente ( Site 0601), Pereira., Risaralda

Fundación Valle del Lili ( Site 0602), Cali, Valle Del Cauca

Regionshospitalet Gødstrup ( Site 1301), Herning, Midtjylland

Aalborg University Hospital ( Site 1302), Aalborg, Nordjylland

Centre Antoine-Lacassagne ( Site 1514), Nice, Alpes-Maritimes

CHU Dijon Bourgogne ( Site 1516), Dijon, Cote-d Or

Institut Curie - site Saint-Cloud ( Site 1501), Saint-Cloud, Hauts-de-Seine

Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren ( Site 1512), Limoges, Limousin

Centre Hospitalier Régional Metz Thionville - Hôpital de Mercy ( Site 1515), Metz, Moselle

Centre Hospitalier de Dunkerque ( Site 1513), Dunkerque, Nord

Centre Hospitalier Universitaire Estaing ( Site 1508), Clermont-Ferrand, Puy-de-Dome

Centre Hospitalier de la Cote Basque ( Site 1509), Bayonne, Pyrenees-Atlantiques

HIA Sainte Anne ( Site 1506), Toulon, Var

Centre Hospitalier d'Avignon ( Site 1505), Avignon, Vaucluse

CHD Vendee ( Site 1502), La Roche-sur-Yon, Vendee

Evangelismos General Hospital of Athens ( Site 1602), Athens, Attiki

General Hospital of Athens "Laiko"-Hematology Department ( Site 1603), Athens, Attiki

Attikon University General Hospital of Athens ( Site 1604), Athens, Attiki

University General Hospital of Alexandroupoli ( Site 1601), Alexandroupolis, Evros

CELAN,S.A ( Site 0702), Guatemala., Not set

MEDI-K ( Site 0701), Guatemala, Not set

Cen Integral Onco Gastro y Hemato Onco Guatemala S.A. ( Site 0703), Guatemala, Not set

Princess Margaret Hospital ( Site 3202), Hong Kong, Not set

Queen Mary Hospital ( Site 3201), Hong Kong, Not set

Carmel Hospital ( Site 1903), Haifa, Not set

Hadassah Medical Center ( Site 1901), Jerusalem, Not set

Sourasky Medical Center ( Site 1904), Tel Aviv, Not set

Poria Medical Center ( Site 1902), Tiberias, Not set

Fondazione IRCCS San Gerardo dei Tintori ( Site 2008), Monza, Lombardia

IRCCS Crob ( Site 2002), Rionero in Vulture, Potenza

Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia ( Site 2010), Candiolo, Torino

AOU delle Marche Ospedali Riuniti di Ancona ( Site 2011), Ancona, Not set

Azienda Ospedaliera Spedali Civili di Brescia-Hemathology ( Site 2001), Brescia, Not set

IRCCS Ospedale San Raffaele ( Site 2012), Milano, Not set

IEO Istituto Europeo di Oncologia ( Site 2009), Milano, Not set

Azienda Ospedaliero Universitaria Maggiore della Carità ( Site 2004), Novara, Not set

Az. Osp. Ospedali Riuniti VILLA SOFIA-CERVELLO ( Site 2005), Palermo, Not set

Ospedale Santa Maria delle Croci ( Site 2006), Ravenna, Not set

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 2003), Roma, Not set

Nagoya University Hospital ( Site 3309), Nagoya, Aichi

National Hospital Organization Shikoku Cancer Center ( Site 3321), Matsuyama, Ehime

Kobe City Medical Center General Hospital ( Site 3318), Kobe, Hyogo

Kanazawa University Hospital ( Site 3308), Kanazawa, Ishikawa

Tokai University Hospital ( Site 3302), Isehara, Kanagawa

Tohoku University Hospital ( Site 3301), Sendai, Miyagi

Kindai University Hospital ( Site 3310), Osakasayama, Osaka

Saitama Medical University Hospital ( Site 3305), Iruma-gun, Saitama

Juntendo University Hospital ( Site 3307), Bunkyo, Tokyo

University of Yamanashi Hospital ( Site 3320), Chuo, Yamanashi

Chiba Cancer Center ( Site 3314), Chiba, Not set

Kyushu University Hospital ( Site 3313), Fukuoka, Not set

Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital ( Site 3322), Hiroshima, Not set

University Hospital,Kyoto Prefectural University of Medicine ( Site 3315), Kyoto, Not set

University of Miyazaki Hospital ( Site 3319), Miyazaki, Not set

Okayama University Hospital ( Site 3311), Okayama, Not set

Osaka Metropolitan University Hospital ( Site 3317), Osaka, Not set

Yamagata University Hospital ( Site 3312), Yamagata, Not set

National Cancer Center- Center for Hemotologic malignancy ( Site 3806), Goyang-si, Kyonggi-do

Pusan National University Hospital ( Site 3804), Busan, Pusan-Kwangyokshi

Chungnam National University Hospital ( Site 3801), Daejeon, Taejon-Kwangyokshi

Severance Hospital, Yonsei University Health System ( Site 3802), Seoul, Not set

Asan Medical Center ( Site 3803), Seoul, Not set

Samsung Medical Center ( Site 3807), Seoul, Not set

St.Mary's H., Youido ( Site 3805), Seoul, Not set

Queen Elizabeth Hospital ( Site 3405), Kota Kinabalu, Sabah

Sarawak General Hospital ( Site 3402), Kuching, Sarawak

Hospital Miri ( Site 3403), Miri, Sarawak

Sunway Medical Centre ( Site 3406), Petaling Jaya, Selangor

Hospital Ampang ( Site 3404), Selangor Darul Ehsan, Selangor

Centro de Infusion Superare ( Site 0804), Ciudad de Mexico, Distrito Federal

Health Pharma Professional Research S.A. de C.V. ( Site 0801), Mexico City, Distrito Federal

Grupo Ollin Care ( Site 0806), Pachuca, Hidalgo

Centro de Investigacion Clinica Chapultepec ( Site 0803), Morelia, Michoacan

Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"" ( Site 0802), Monterrey, Nuevo Leon

Centro de Investigacion Clinica de Oaxaca ( Site 0805), Oaxaca, Not set

Meander Medisch Centrum ( Site 2101), Amersfoort, Utrecht

Albert Schweitzer Ziekenhuis ( Site 2103), Dordrecht, Zuid-Holland

Clínicas AUNA Sede Chiclayo ( Site 0904), Chiclayo, Lambayeque

Clínica San Felipe ( Site 0906), Lima, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 2201), Warszawa, Mazowieckie

Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku ( Site 2210), Słupsk, Pomorskie

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2208), Gliwice, Slaskie

Pratia Onkologia Katowice ( Site 2204), Katowice, Slaskie

Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onko ( Site 2205), Olsztyn, Warminsko-mazurskie

Unidade Local de Saude de Braga - Hospital de Braga ( Site 2306), Braga, Not set

Instituto Portugues de Oncologia Do Porto Francisco Gentil E.P.E. ( Site 2302), Porto, Not set

BRCR Global - Mayaguez ( Site 1003), Mayaguez, Not set

Auxilio Mutuo Cancer Center ( Site 1001), San Juan, Not set

Institutul Oncologic Cluj ( Site 2404), Cluj-Napoca, Cluj

Centrul de Diagnostic si Tratament Oncologic Brasov ( Site 2402), Brasov, Not set

Spital Judetean Sibiu ( Site 2405), Sibiu, Not set

National University Hospital ( Site 3702), Singapore, Central Singapore

National Cancer Centre Singapore ( Site 3701), Singapore, Central Singapore

Haemalife ( Site 2501), Cape Town, Western Cape

Hospital Universitario Virgen Macarena ( Site 2608), Sevilla, Andalucia

ICO L Hospitalet ( Site 2601), Hospitalet de Llobregat, Barcelona

H. Insular de Gran Canaria ( Site 2606), Las Palmas de Gran Canaria, Las Palmas

Hospital General Universitario Dr. Balmis ( Site 2604), Alicante, Valenciana, Comunitat

Hospital del Mar ( Site 2610), Barcelona, Not set

Hospital Universitario La Paz ( Site 2611), Madrid, Not set

Hospital Virgen de la Victoria ( Site 2609), Malaga, Not set

Hospital Universitario Miguel Servet ( Site 2607), Zaragoza, Not set

Kantonspital Baden ( Site 2703), Baden, Aargau

Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 2702), St. Gallen, Sankt Gallen

Ospedale Regionale Bellinzona e Valli ( Site 2701), Bellinzona, Ticino

Chang Gung Memorial Hospital - Linkou Branch ( Site 3903), Taoyuan City, Taoyuan

Chang Gung Memorial Hospital at Kaohsiung ( Site 3905), Kaohsiung, Not set

National Cheng Kung University Hospital ( Site 3902), Tainan, Not set

National Taiwan University Hospital ( Site 3901), Taipei, Not set

Mackay Memorial Hospital ( Site 3908), Taipei, Not set

Tri-Service General Hospital ( Site 3906), Taipei, Not set

Maharaj Nakorn Chiang Mai Hospital ( Site 4002), Muang, Chiang Mai

Faculty of Medicine Siriraj Hospital ( Site 4001), Bangkoknoi, Krung Thep Maha Nakhon

Chulalongkorn University ( Site 4003), Pathumwan, Krung Thep Maha Nakhon

Hacettepe Universite Hastaneleri ( Site 2810), Ankara, Not set

Ankara University Faculty of Medicine ( Site 2801), Ankara, Not set

MNPE ClinCenter of Oncology,Hematology,Transplantology and Palliative Care of CherkasyRegCouncil ( Site 2904), Cherkasy, Cherkaska Oblast

Communal non-profit enterprise "Regional clinical hospital of Ivano-Frankivsk Regional Council" ( Site 2906), Ivano-Frankivsk, Ivano-Frankivska Oblast

Khmelnytskyi Regional Hospital ( Site 2907), Khmelnytskiy, Khmelnytska Oblast

Institute of Blood Pathology and Transfusion Medicine AMS Ukraine ( Site 2903), Lviv, Lvivska Oblast

SNPE National Cancer Institute ( Site 2902), Kyiv, Not set

Universal Clinic Oberig ( Site 2908), Kyiv, Not set

SI National Research Center of Radiation Medicine, Hematology, Oncology ( Site 2901), Kyiv, Not set

Public Non-Profit Enterprise Kyiv City Clinical Hospital #9 under the Executive Body of Kyiv City Co ( Site 2905), Kyiv, Not set

Conditions: Diffuse Large B-Cell Lymphoma

Learn More ›

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

NCT06870487

Recruiting

The purpose of this study is to learn about the effects of a new study medicine called PF-08046032, when taken alone and when taken with another medicine called sasanlimab, for the treatment of advanced cancers. The effects are studied in adult participants with certain types of lymphomas or solid tumors that are advanced or metastatic (spread to other parts of the body). The study has three parts: * Part A will test PF-08046032 alone at increasing dose levels in participants with certain lymp... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/14/2025

Locations: Highlands Oncology Group, PA, Fayetteville, Arkansas +8 locations

Conditions: Peripheral T Cell Lymphoma, Diffuse Large B-cell Lymphoma, Classical Hodgkin Lymphoma, Head and Neck Squamous Cell Carcinoma, Melanoma, Non-Small Cell Lung Cancer

Learn More ›

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

NCT05512390

Recruiting

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Follicular Lymphoma is a slow-growing type of non-Hodgkin lymphoma. Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of ABBV-319 in adult participants in relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL)... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/12/2025

Locations: University of Arizona Cancer Center - Tucson /ID# 247752, Tucson, Arizona +17 locations

Conditions: Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, Follicular Lymphoma

Learn More ›

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

NCT03223610

Recruiting

Background: B-cell lymphoma is a cancer of white blood cells found in the lymph nodes. It affects the system that fights infections and disease. Researchers want to learn how certain drugs work together to treat B-cell lymphomas. The drugs are venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR). Objective: To study the safety of ViPOR for people with B-cell lymphoma. Eligibility: People ages 18 and older with B-cell lymphoma whose cancer has returned or not improved af... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/09/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Burkitt Lymphoma

Learn More ›

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT06806033

Recruiting

The main goal of this trial is to study the frequency and severity of cytokine release syndrome (CRS) in participants with diffuse large B-cell lymphoma (DLBCL) who are using a combination of glofitamab + gemcitabine + oxaliplatin (Glofit-GemOx) followed by glofitamab-only treatment.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/08/2025

Locations: Alaska Oncology & Hematology, LLC, Anchorage, Alaska +33 locations

Alaska Oncology & Hematology, LLC, Anchorage, Alaska

Providence Medical Foundation, Fullerton, California

Valkyrie Clinical Trials, Los Angeles, California

Zuckerberg San Francisco General Hospital, San Francisco, California

Rocky Mountain Cancer Centers, LLP, Aurora, Colorado

Mount Sinai Comprehensive Cancer Center, Miami, Florida

St Luke?s Cancer Institute, Boise, Idaho

Cancer Care Specialists of Central Illinois, Swansea, Illinois

University of Kentucky - Markey Cancer Center, Lexington, Kentucky

Boston Medical Center, Boston, Massachusetts

Nebraska Cancer Specialists, Omaha, Nebraska

New York Oncology Hematology, P.C., Albany, New York

Oncology Associates of Oregon, P.C, Eugene, Oregon

Texas Oncology - Gulf Coast, The Woodlands, Texas

Texas Oncology- Northeast Texas, Tyler, Texas

Virginia Cancer Specialists, PC, Gainesville, Virginia

Virginia Oncology Associates - Virginia Beach, Virginia Beach, Virginia

Northwest Medical Specialties, Tacoma, Washington

Arthur J.E. Child Comprehensive Cancer Center, Calgary, Alberta

CancerCare Manitoba (CCMB), Winnipeg, Manitoba

CHU de Grenoble, La Tronche, Not set

Chu de Montpellier-St Eloi, Montpellier, Not set

CHU de Bordeaux, Pessac, Not set

CHU DE RENNES - CHU Pontchaillou, Rennes, Not set

Chu De Tours, Tours, Not set

Otto von Guericke Uni Magdeburg Uniklinik, Magdeburg, Not set

Istituto Nazionale Tumori Irccs Fondazione g. Pascale, Napoli, Campania

IRCCS Istituto Romagnolo per lo studio dei tumori "Dino Amadori", Meldola, Emilia-Romagna

A.O. Spedali Civili Di Brescia-P.O. Spedali Civili, Brescia, Lombardia

Irccs Istituto Europeo Di Oncologia (IEO), Milano, Lombardia

Istituto Clinico Humanitas, Rozzano, Lombardia

Seoul National University Bundang Hospital, Seongnam-si, Not set

Seoul National University Hospital, Seoul, Not set

Asan Medical Center, Seoul, Not set

Conditions: Diffuse Large B-Cell Lymphoma

Learn More ›

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

NCT02393157

Recruiting

The purpose of this study is to determine the safety of administering obinutuzumab as a single agent alone and in combination with ifosfamide, carboplatin, and etoposide (ICE) chemotherapy and determine the response rate of this treatment for children, adolescents and young adults (CAYA) with relapsed CD20 positive B-cell Non-Hodgkin Lymphoma (B-NHL).

Gender:

ALL

Ages:

Between 3 years and 31 years

Trial Updated:

08/07/2025

Locations: New York Medical College, Valhalla, New York

Conditions: Non-Hodgkin Lymphoma, Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, Primary Mediastinal B-cell Lymphoma, CD20+ Lymphoblastic Lymphoma, Follicular Lymphoma, Grade III

Learn More ›

A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT06508658

Recruiting

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). This study will assess how safe and effective epcoritamab plus lenalidomide (E-Len) is compared to rituximab plus gemcitabine and oxaliplatin (R-GemOx) )in treating adult participants with relapsed or refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). Adverse events and change in disease condition will be assessed. Epcoritamab is an investigational drug being... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/04/2025

Locations: City of Hope National Medical Center /ID# 273338, Duarte, California +152 locations

City of Hope National Medical Center /ID# 273338, Duarte, California

Valkyrie Clinical Trials /ID# 269935, Los Angeles, California

Lutheran Medical Center- Cancer Centers of Colorado /ID# 265823, Golden, Colorado

City Of Hope Cancer Center - Atlanta /ID# 273092, Newnan, Georgia

City of Hope, Chicago /ID# 274430, Zion, Illinois

Northwest Cancer Center - Dyer Clinic /ID# 269787, Dyer, Indiana

Cancer Center of Kansas - Wichita /ID# 270117, Wichita, Kansas

University of Kentucky Chandler Medical Center /ID# 242087, Lexington, Kentucky

University of Maryland, Baltimore /ID# 242216, Baltimore, Maryland

Henry Ford Hospital /ID# 266446, Detroit, Michigan

Gulfport Memorial Hospital /ID# 268104, Gulfport, Mississippi

New York Medical College /ID# 265799, Valhalla, New York

East Carolina University - Brody School of Medicine /ID# 242227, Greenville, North Carolina

Thompson Cancer Survival Ctr /ID# 242149, Knoxville, Tennessee

Community Cancer Trials Of Utah /ID# 271715, Ogden, Utah

Utah Cancer Specialists - Salt Lake City /ID# 268603, Salt Lake City, Utah

Veterans Affairs Medical Center - Salt Lake City /ID# 265329, Salt Lake City, Utah

Canberra Hospital /ID# 265312, Garran, Australian Capital Territory

Royal Prince Alfred Hospital /ID# 263242, Sydney, New South Wales

Wollongong Hospital /ID# 244646, Wollongong, New South Wales

Toowoomba Hospital /ID# 263243, Toowoomba, Queensland

Monash Health - Monash Medical Centre /ID# 262783, Clayton, Victoria

Royal Perth Hospital /ID# 243790, Perth, Western Australia

Universitair Ziekenhuis Brussel /ID# 242574, Jette, Bruxelles-Capitale

Centre Hospitalier Epicura - site d'Hornu /ID# 265148, Boussu, Hainaut

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant /ID# 242565, Yvoir, Namur

Universitair Ziekenhuis Leuven /ID# 246671, Leuven, Vlaams-Brabant

AZ-Delta /ID# 264740, Roeselare, West-Vlaanderen

UMHAT Sveti Georgi /ID# 242905, Plovdiv, Not set

UMHAT Sveti Ivan Rilski /ID# 242389, Sofia, Not set

SHAT Hematologic Diseases /ID# 242708, Sofia, Not set

UMHAT Multiprofile Hospital for Active Treatment Sveta Marina /ID# 262761, Varna, Not set

CIUSSS de l'est de l'Ile-de-Montreal - Hopital Maisonneuve-Rosemont /ID# 262751, Montreal, Quebec

Peking University Third Hospital /ID# 242941, Beijing, Beijing

Fujian Province Cancer Hospital /ID# 265075, Fuzhou, Fujian

The First Affiliated Hospital of Xiamen /ID# 264305, Xiamen, Fujian

Sun Yat-Sen University Cancer Center /ID# 242712, Guangzhou, Guangdong

Guangdong Provincial People's Hospital /ID# 242942, Guangzhou, Guangdong

The Second Hospital of Hebei Medical University /ID# 242944, Shijiazhuang, Hebei

Harbin Medical University Cancer Hospital /Id# 242961, Harbin, Heilongjiang

Henan Cancer Hospital /ID# 242700, Zhengzhou, Henan

Union Hospital affiliated to Tongji Medical College of Huazhong University of Sc /ID# 242702, Wuhan, Hubei

Hubei Cancer Hospital /ID# 242963, Wuhan, Hubei

The First Affiliated Hospital of Soochow University /ID# 242939, Suzhou, Jiangsu

The First Affiliated Hospital of Nanchang University /ID# 242703, Nanchang, Jiangxi

Jiangxi Provincial Cancer Hospital /ID# 242968, Nanchang, Jiangxi

The First Hospital of Jilin University /ID# 242940, Changchun, Jilin

The First Hospital of China Medical University /ID# 242701, Shenyang, Liaoning

Shandong Cancer Hospital /ID# 264036, Jinan, Shandong

Shanghai Tongji Hospital /ID# 263952, Shanghai, Shanghai

Tianjin Cancer Hospital /ID# 243940, Tianjin, Tianjin

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 243139, Tianjin, Tianjin

The Affiliated Cancer Hospital of Xinjiang Medical University /ID# 242966, Urumqi, Xinjiang

Yunnan Province Cancer Hospital /ID# 264057, Kunming, Yunnan

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 242960, Hangzhou, Zhejiang

The second affiliated hospital of Zhejiang University school of medicine /ID# 243137, Hangzhou, Zhejiang

Zhejiang Cancer hospital /ID# 242711, Hangzhou, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University /ID# 263951, Wenzhou, Zhejiang

Klinicka bolnica Merkur /ID# 262619, Zagreb, Grad Zagreb

Klinicki bolnicki centar Sestre milosrdnice /ID# 262620, Zagreb, Grad Zagreb

Klinicki bolnicki centar Zagreb /ID# 262617, Zagreb, Grad Zagreb

Klinicki bolnicki centar Osijek /ID# 262621, Osijek, Osjecko-baranjska Zupanija

Klinički Bolnički Centar Rijeka /ID# 266004, Rijeka, Primorsko-goranska Zupanija

Klinicki Bolnicki Centar (KBC) Split /ID# 262618, Split, Splitsko-dalmatinska Zupanija

Fakultní nemocnice Hradec Králové - Sokolská /ID# 264071, Hradec Králové, Hradec Kralove

Institut de cancérologie Strasbourg Europe (ICANS) /ID# 264068, Strasbourg, Bas-Rhin

CHU de CAEN - Hopital de la Cote de Nacre /ID# 243075, Caen, Calvados

CHRU Tours - Hopital Bretonneau /ID# 244580, Tours CEDEX 9, Indre-et-Loire

Centre Hospitalier D'Avignon /ID# 243072, Avignon, Provence-Alpes-Cote-d Azur

Centre Hospitalier de la Cote Basque /ID# 243065, Bayonne, Pyrenees-Atlantiques

CHU Poitiers - La miletrie /ID# 243074, Poitiers, Vienne

Hopital Saint Vincent de Paul /ID# 243070, Lille Cedex, Not set

General Hospital of Athens Laiko /ID# 262809, Athens, Attiki

University General Hospital Attikon /ID# 242041, Athens, Attiki

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 242039, Athens, Not set

General University Hospital of Thessaloniki AXEPA /ID# 242038, Thessaloniki, Not set

Theageneio Anticancer Hospital /ID# 242036, Thessaloniki, Not set

Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 262924, Pecs, Baranya

Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz /ID# 262901, Gyor, Gyor-Moson-Sopron

Debreceni Egyetem-Klinikai Kozpont /ID# 242451, Debrecen, Hajdu-Bihar

Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz /ID# 242468, Nyiregyhaza, Szabolcs-Szatmar-Bereg

Semmelweis Egyetem /ID# 242455, Budapest, Not set

Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet /ID# 262923, Budapest, Not set

Orszagos Onkologiai Intezet /ID# 242457, Budapest, Not set

Fujita Health University Hospital /ID# 265968, Toyoake, Aichi

National Hospital Organization Shikoku Cancer Center /ID# 265977, Matsuyama, Ehime

Kyushu University Hospital /ID# 267624, Fukuoka-shi, Fukuoka

Fukushima Medical University Hospital /ID# 264667, Fukushima-shi, Fukushima

Sapporo Medical University Hospital /ID# 264928, Sapporo, Hokkaido

Kagoshima University Hospital /ID# 248259, Kagoshima-shi, Kagoshima

Tokai University Hospital /ID# 265433, Isehara, Kanagawa

Kansai Medical University Hirakata Hospital /ID# 266018, Hirakata-shi, Osaka

Kindai University Hospital /ID# 265474, Osaka sayama-shi, Osaka

Saitama Cancer Center /ID# 265277, Kitaadachi-gun, Saitama

University of Yamanashi Hospital /ID# 264671, Chuo-shi, Yamanashi

Inje University - Busan Paik Hospital /ID# 262842, Busan, Busan Gwang Yeogsi

Dong-A University Medical Center /ID# 262841, Busan, Busan Gwang Yeogsi

Seoul National University Bundang Hospital /ID# 242405, Seongnam-si, Gyeonggido

Keimyung University Dongsan Hospital /ID# 262840, Daegu, Gyeongsangbugdo

Jeonbuk National University Hospital /ID# 242958, Jeonju, Jeonrabugdo

Chonnam National University Hwasun Hospital /ID# 262843, Hwasun-gun, Jeonranamdo

Seoul National University Hospital /ID# 242407, Seoul, Seoul Teugbyeolsi

Asan Medical Center /ID# 242409, Seoul, Seoul Teugbyeolsi

Samsung Medical Center /ID# 242408, Seoul, Seoul Teugbyeolsi

The Catholic University of Korea, Seoul St. Marys Hospital /ID# 242406, Seoul, Seoul Teugbyeolsi

Ulsan University Hospital /ID# 242956, Ulsan, Ulsan Gwang Yeogsi

Centro De Investigación Clinica Chapultepec /ID# 243959, Mexico City, Ciudad De Mexico

Centro de Quimioterapia E Investigacion Sas de Cv /Id# 263293, Jalisco, Not set

Medisch Centrum Leeuwarden /ID# 245501, Leeuwarden, Friesland

Jeroen Bosch Ziekenhuis, locatie 's-Hertogenbosch /ID# 265204, 's-Hertogenbosch, Noord-Brabant

OLVG - Locatie Oost /ID# 263355, Amsterdam, Noord-Holland

St. Antonius Ziekenhuis /ID# 245197, Nieuwegein, Utrecht

Albert Schweitzer Ziekenhuis, locatie Dordwijk /ID# 263361, Dordrecht, Zuid-Holland

North Shore Hospital /ID# 266060, Auckland, Not set

Wellington Hospital /ID# 265966, Wellington, Not set

Pratia MCM Krakow /ID# 262882, Krakow, Malopolskie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Bada /ID# 263314, Warsaw, Mazowieckie

Swietokrzyskie Centrum Onkologii Samodzielny Publiczny Zaklad Opieki Zdrowotnej /ID# 242436, Kielce, Swietokrzyskie

Aidport sp z o.o. /ID# 262766, Poznan, Wielkopolskie

Hospital da Luz /ID# 262965, Lisbon, Lisboa

Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE /ID# 262961, Porto, Not set

Unidade Local de Saude Sao Joao, EPE /ID# 262962, Porto, Not set

Fundeni Clinical Institute /ID# 266734, Bucharest, Bucuresti

Institutul Oncologic Prof Dr. Ion Chiricuta Cluj Napoca /ID# 243753, Cluj-Napoca, Cluj

Institutul Regional de Oncologie /ID# 244367, Jassi, Iasi

Spitalul Clinic Coltea /ID# 243694, Bucharest, Not set

Clinical Hospital Center Zvezdara /ID# 263059, Belgrade, Beograd

Institute for Oncology and Radiology of Serbia /ID# 263055, Belgrade, Beograd

University Clinical Center Serbia /ID# 263057, Belgrade, Beograd

Clinical Hospital Center - Bežanijska Kosa /ID# 263053, Belgrade, Beograd

University Clinical Center Nis /ID# 263701, Niš, Nisavski Okrug

Institute for Oncology of Vojvodina /ID# 263052, Sremska Kamenica, Vojvodina

University Clinical Center Vojvodina /ID# 264138, Novi Sad, Not set

National Cancer Centre Singapore /ID# 267015, Singapore, Central Singapore

National University Hospital /ID# 264016, Singapore, Not set

Tan Tock Seng Hospital /ID# 266061, Singapore, Not set

Wits Clinical Research /ID# 264656, Johannesburg, Gauteng

Alberts Cellular Therapy /ID# 262720, Pretoria, Gauteng

Constantiaberg Haematology /ID# 273041, Cape Town, Western Cape

Haemalife Inc. /ID# 262719, Kuilsrivier, Western Cape

National Taiwan University Hospital /ID# 243300, Taipei City, Taipei

China Medical University Hospital /ID# 242931, Taichung, Not set

Taichung Veterans General Hospital /ID# 242937, Taichung, Not set

National Cheng Kung University Hospital /ID# 243301, Tainan, Not set

Ankara Universitesi Fakultesi /ID# 242410, Ankara, Not set

Adnan Menderes University /ID# 242418, Aydin, Not set

Trakya University Medical Facu /ID# 242419, Edirne, Istanbul, Not set

Ege University Medical Faculty /ID# 242417, Izmir, Not set

Ondokuz mayis University Facul /ID# 242412, Samsun, Not set

Karadeniz Technical University Farabi Hospital /ID# 264694, Trabzon, Not set

Istanbul Florence Nightingale Hospital /ID# 271544, Şişli, Not set

Nottingham City Hospital /ID# 265129, Nottingham, Nottinghamshire

The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 242923, Newcastle upon Tyne, Not set

Conditions: Diffuse Large B-Cell Lymphoma

Learn More ›

1 - 12 of 33